Renerio Fraguas

Prof. Dr. Renerio Fraguas

University of São Paulo Medical School, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2017 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
ABAndre R. Brunoni
Andre R. Brunoni
AMAdriano H. Moffa
Adriano H. Moffa
BSBernardo Sampaio-Junior
Bernardo Sampaio-Junior
LBLucas Borrione
Lucas Borrione
MMMarina L. Moreno
Marina L. Moreno
IBIsabela M. Benseñor
Isabela M. Benseñor
We compared transcranial direct-current stimulation (tDCS) with a selective serotonin-reuptake inhibitor for the treatment of depression.

1 February 2018 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
BSBernardo Sampaio-Junior
Bernardo Sampaio-Junior
GTGabriel Tortella
Gabriel Tortella
LBLucas Borrione
Lucas Borrione
AMAdriano H. Moffa
Adriano H. Moffa
RMRodrigo Machado-Vieira
Rodrigo Machado-Vieira
ABAndre R. Brunoni
Andre R. Brunoni
Bipolar disorder presents a high burden.1 Depressive episodes are more frequent, prolonged, and incapacitating compared with manic ones.2 Therapeutic options for bipolar depression (BD) have adverse effects and modest efficacy.3 Electroconvulsive therapy, although effective for BD,4 requires sedation, short-term hospitalization, and pharmacologic adjustments. Repetitive transcranial magnetic stimulation, a noninvasive brain stimulation approach, showed positive results for unipolar depression5 and BD.6,7 However, repetitive transcranial magnetic stimulation is expensive and associated with seizures.8

21 April 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FGFranciele Cordeiro Gabriel
Franciele Cordeiro Gabriel
DMDaniela Oliveira de Melo
Daniela Oliveira de Melo
RFRenerio Fraguas
Renerio Fraguas
NLNathália Celini Leite-Santos
Nathália Celini Leite-Santos
RSRafael Augusto Mantovani da Silva
Rafael Augusto Mantovani da Silva
EREliane Ribeiro
Eliane Ribeiro
Depression affects over 300 million individuals worldwide and is responsible for most of the 800,000 annual suicides. Clinical practice guidelines (CPGs) for treatment of depression, founded on scientific evidence, are essential to improve patient care. However, economic and sociocultural factors may influence CPG elaboration, potentially leading to divergences in their recommendations. Consequently, we analyzed pharmacological recommendations for the treatment of depression from the most relevant CPGs. We included four CPGs with scores ≥ 80% for Domain 3 (rigor of development) on the Appraisal of Guidelines for Research and Evaluation and two other commonly used CPGs. The recommendations, their strengths, and the level of evidence were extracted from each CPG by two independent researchers and grouped as follows: (1) general recommendations for the pharmacological treatment for depression (suicide risk, acute treatment, continuation and maintenance phases, and treatment discontinuation); (2) treatment of non-responsive or partially responsive patients; and (3) treatment for subtypes of depression (chronic, psychotic, catatonic, melancholic, seasonal, somatic, mixed, and atypical). Only 50% of CPGs included recommendations for the risk of suicide associated with pharmacotherapy. All CPGs included serotonin selective reuptake inhibitors (SSRIs) as first-line treatment; however, one CPG also included agomelatine, milnacipran, and mianserin as first-line alternatives. Recommendations for depression subtypes (catatonic, atypical, melancholic) were included in three CPGs. The strength of recommendation and level of evidence clearly differed among CPGs, especially regarding treatment augmentation strategies. We conclude that, although CPGs converged in some recommendations (e.g., SSRIs as first-line treatment), they diverged in cardinal topics including the absence of recommendations regarding the risk of suicide associated with pharmacotherapy. Consequently, the recommendations listed in a specific CPG should be followed with caution.

12 April 2011 in The World Journal of Biological Psychiatry
Verified
Journal Article
Open access
LTLuisa Terroni
Luisa Terroni
EAEdson Amaro
Edson Amaro
DIDan V. Iosifescu
Dan V. Iosifescu
GTGisela Tinone
Gisela Tinone
JSJoão Ricardo Sato
João Ricardo Sato
RFRenerio Fraguas
Renerio Fraguas
Little is known about the relevance of lesion in neural circuits reported to be associated with major depressive disorder. We investigated the association between lesion stroke size in the limbic-cortical-striatal-pallidal-thalamic (LCSPT) circuit and incidence of major depressive episode (MDE). We enrolled 68 patients with first-ever ischemic stroke and no history of major depressive disorder. Neurological and psychiatric examinations were performed at three time-points. We diagnosed major depressive episode, following DSM-IV criteria. Lesion location and volume were determined with magnetic resonance imaging, using a semi-automated method based on the Brodmann Cytoarchitectonic Atlas. Twenty-one patients (31%) experienced major depressive episode. Larger lesions in the left cortical regions of the LCSPT circuit (3,760 vs. 660 mm3; P = 0.004) were associated with higher incidence of MDE. Secondary analyses revealed that major depressive episode was associated with larger lesions in areas of the medial prefrontal cortex including the ventral (BA24) and dorsal anterior cingulate cortex (BA32) and subgenual cortex (BA25); and also the subiculum (BA28/36) and amygdala (BA34). Our findings indicate that depression due to stroke is aetiologically related to the disruption of the left LCSPT circuit and support the relevance of the medial prefrontal cortex dysfunction in the pathophysiology of depression.

15 February 2005 in The Journal of Clinical Psychiatry
Verified
Journal Article
Closed access
PDF file
RPRoy H. Perlis
Roy H. Perlis
RFRenerio Fraguas
Renerio Fraguas
MFMaurizio Fava
Maurizio Fava
MTMadhukar H. Trivedi
Madhukar H. Trivedi
JLJames F. Luther
James F. Luther
ARA. John Rush
A. John Rush
From The Journal of Clinical Psychiatry:

1 March 2006 in Journal of Affective Disorders
Verified
Journal Article
Closed access
RFRenerio Fraguas
Renerio Fraguas
SGS Gonsalveshenriquesjr
S Gonsalveshenriquesjr
MDM Delucia
M Delucia
DID Iosifescu
D Iosifescu
FSF Schwartz
F Schwartz
MAM Arrudamartins
M Arrudamartins